These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 898533)
1. An historical view of the medical-social aspects of the UGDP. Knowles HC Trans Am Clin Climatol Assoc; 1977; 88():150-6. PubMed ID: 898533 [No Abstract] [Full Text] [Related]
2. [University Group Diabetes Program. The UGDP investigation remains clinically unacceptable]. Aarseth S Tidsskr Nor Laegeforen; 1976 Aug; 96(22):1148. PubMed ID: 951693 [No Abstract] [Full Text] [Related]
3. The UGDP--tolbutamide and mortality. Knowles HC Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432 [No Abstract] [Full Text] [Related]
4. Audit confirms conclusions of UGDP study on oral diabetes drugs. FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):34-6. PubMed ID: 720789 [No Abstract] [Full Text] [Related]
5. Comments on the UGDP study. Schöffling K Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018 [No Abstract] [Full Text] [Related]
6. [Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged]. Teuscher A Schweiz Med Wochenschr; 1972 Jun; 102(24):848-55. PubMed ID: 5033623 [No Abstract] [Full Text] [Related]
7. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation]. Pirart J Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448 [No Abstract] [Full Text] [Related]
8. Editorials: Statistical problems in clinical trials: the UGDP study revisited. Schor SS Am J Med; 1973 Dec; 55(6):727-32. PubMed ID: 4584989 [No Abstract] [Full Text] [Related]
10. Oral diabetic drugs again held hazardous. J Tenn Med Assoc; 1975 Apr; 68(4):343. PubMed ID: 1117724 [No Abstract] [Full Text] [Related]
11. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results. Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344 [No Abstract] [Full Text] [Related]
12. Misunderstanding or error? The UGDP report after four years. Marigo S; Adezati L; Burnetti P; Pozza G; Robba L; Urbinati G Acta Diabetol Lat; 1974; 11(5):357-422. PubMed ID: 4156992 [No Abstract] [Full Text] [Related]
13. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026 [No Abstract] [Full Text] [Related]
15. [Oral therapy in diabetes]. Kirkeby K Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1620-1. PubMed ID: 4588817 [No Abstract] [Full Text] [Related]
16. [Should the prescription of oral antidiabetic drugs be more limited? Results from controlled clinical trials]. Folling I Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1604-6. PubMed ID: 4769481 [No Abstract] [Full Text] [Related]
17. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP). Seltzer HS Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722 [No Abstract] [Full Text] [Related]
18. [Heart death and oral antidiabetics; the last judgement]. Touber JL Ned Tijdschr Geneeskd; 1975 Sep; 119(39):1506-8. PubMed ID: 1101083 [No Abstract] [Full Text] [Related]